logo-loader
RNS
Science Group PLC

Transaction in Own Shares

RNS Number : 3091D
Science Group PLC
16 November 2026
 

S:\Clients\Clients R - Z\Sagentia\Graphics\Science_Group_black_300dpi.jpg

16 November 2026

 

Science Group plc

(the “Company” or “Science Group”)

 

Transaction in own shares

 

Science Group plc (AIM:SAG) announces that, in the period from 9 November 2026 to 12 November 2026, it purchased 52,000 of its 1 pence ordinary shares. The Company purchased these shares through Panmure Liberum Limited.

 

Date

Aggregated Volume

Volume Weighted Average Price

Lowest Price per Share

Highest Price per Share

Venue

9 November 2026

13,000

£5.68

£5.68

£5.68

AIMX

10 November 2026

13,000

£5.68

£5.68

£5.68

AIMX

11 November 2026

13,000

£5.68

£5.68

£5.68

AIMX

12 November 2026

13,000

£5.67

£5.67

£5.67

AIMX

 

The number of shares purchased represented 0.13% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 40,035,593. Science Group holds 6,150,281 shares in treasury.

 

The figure of 40,035,593 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

Schedule of Purchases - Individual Transactions

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Liberum Limited on behalf of the Company as part of the buyback programme.

 

Date

Number of

Shares Purchased

Transaction Price (per share)

Time of Transaction

Execution Venue

9 November 2026

13,000

£5.68

10:27:35

AIMX

10 November 2026

13,000

£5.68

08:15:59

AIMX

11 November 2026

13,000

£5.68

09:07:33

AIMX

12 November 2026

13,000

£5.67

12:24:11

AIMX

 

 

- Ends -

For further information:

Science Group plc

 

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

 

Panmure Liberum Limited (Nomad and Joint Broker)

 

Nicholas How, Rupert Dearden

Tel: +44 (0) 20 3100 2000

 

 

Peel Hunt LLP (Joint Broker)

 

Neil Patel, Kate Bannatyne

Tel : +44(0)20 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAKABKKBDDQDD
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

1 week, 3 days ago

Transaction in Own Shares

1 week, 3 days ago

Change to buyback reporting

2 weeks, 3 days ago

Total Voting Rights

2 weeks, 3 days ago

Transaction in Own Shares

3 weeks, 1 day ago

Transaction in Own Shares

3 weeks, 2 days ago

Transaction in Own Shares

3 weeks, 3 days ago

2 min read